|
| Exchange Disseminated Time 19/05/2017 15:18:31 | Marksans Pharma Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on May 29, 2017, to consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended March 31, 2017. The Board of Directors will also consider recommendation of dividend, if any, for the Financial Year 2016-17.
Further, as per the Insider Trading Code of the Company, the Trading Window for dealing in Company's shares will remain closed for the Company's insiders from May 19, 2017 (commencing from the time of above intimation to the Stock Exchanges) till Forty-Eight hours after the announcement of the Financial Results on May 29, 2017. |
|
|